Gene · 10288
Papers2,402
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,402
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: Mass spectrometry-based proteogenomics - advances in mutant proteomics and clinical oncology. | Front Oncol | 2024 | 38577326 | PubTator, text mining | PubMed |
| Cancer cell immunity-related protein co-expression networks are associated with early-stage solid-predominant lung adenocarcinoma. | Front Oncol | 2024 | 38450191 | PubTator, text mining | PubMed |
| ILT4 facilitates angiogenesis in non-small cell lung cancer. | Cancer Sci | 2024 | 38433526 | PubTator, text mining | PubMed |
| Identification of neutrophil extracellular trap-driven gastric cancer heterogeneity and C5AR1 as a therapeutic target. | Acta Biochim Biophys Sin (Shanghai) | 2024 | 38425243 | PubTator, text mining | PubMed |
| Validation of the interaction between PRDX4 and TXNDC5 in gastric cancer and the significance of the PRDX4 gene in gastric cancer based on a data mining analysis. | Transl Cancer Res | 2024 | 38410208 | PubTator, text mining | PubMed |
| ILT2 and ILT4 Drive Myeloid Suppression via Both Overlapping and Distinct Mechanisms. | Cancer Immunol Res | 2024 | 38393969 | PubTator, text mining | PubMed |
| Analysis of HLA-G 14 bp Insertion/Deletion Polymorphism and HLA-G, ILT2 and ILT4 Expression in Head and Neck Squamous Cell Carcinoma Patients. | Diseases | 2024 | 38391781 | PubTator, text mining | PubMed |
| Assessing the impact of novel risk loci on Alzheimer's and Parkinson's diseases in a Chinese Han cohort. | Front Neurol | 2024 | 38356889 | PubTator, text mining | PubMed |
| Leukocyte immunoglobulin-like receptor B2: A promising biomarker for colorectal cancer. | World J Gastroenterol | 2024 | 38313233 | PubTator, text mining | PubMed |
| Revolutionizing cancer care strategies: immunotherapy, gene therapy, and molecular targeted therapy. | Mol Biol Rep | 2024 | 38281269 | PubTator, text mining | PubMed |
| Activation of GPR3-β-arrestin2-PKM2 pathway in Kupffer cells stimulates glycolysis and inhibits obesity and liver pathogenesis. | Nat Commun | 2024 | 38280848 | PubTator, text mining | PubMed |
| Identification of shared pathogenetic mechanisms between COVID-19 and IC through bioinformatics and system biology. | Sci Rep | 2024 | 38267482 | PubTator, text mining | PubMed |
| Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor Targeting. | Cancers (Basel) | 2024 | 38254772 | PubTator, text mining | PubMed |
| Low expression of PRRG2 in kidney renal clear cell carcinoma: an immune infiltration-associated prognostic biomarker. | Discov Oncol | 2024 | 38227081 | PubTator, text mining | PubMed |
| Associations between genetically predicted plasma protein levels and Alzheimer's disease risk: a study using genetic prediction models. | Alzheimers Res Ther | 2024 | 38212844 | PubTator, text mining | PubMed |
| Immune and stromal transcriptional patterns that influence the outcome of classic Hodgkin lymphoma. | Sci Rep | 2024 | 38184757 | PubTator, text mining | PubMed |
| miRNAs and related genetic biomarkers according to the WHO glioma classification: From diagnosis to future therapeutic targets. | Noncoding RNA Res | 2024 | 38035044 | PubTator, text mining | PubMed |
| Regulatory Variants on the Leukocyte Immunoglobulin-Like Receptor Gene Cluster are Associated with Crohn's Disease and Interact with Regulatory Variants for TAP2. | J Crohns Colitis | 2024 | 37523193 | PubTator, text mining | PubMed |
| Utilizing exosomes as sparking clinical biomarkers and therapeutic response in acute myeloid leukemia. | Front Immunol | 2023 | 38292478 | PubTator, text mining | PubMed |
| Unraveling the regulatory network of miRNA expression in Potato Y virus-infected of Nicotiana benthamiana using integrated small RNA and transcriptome sequencing. | Front Genet | 2023 | 38259624 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10288/papers?page=6